Sign In
NewsRadar

Wilson Therapeutics

Wilson Therapeutics AB is a biopharmaceutical company focused on developing treatments for Wilson Disease, a rare genetic disease that effects approximately 1 in 15,000. Wilson Therapeutics was founded in 2012.

Wilson Therapeutics’ lead compound, WTX101, is the proprietary bis-choline salt of tetrathiomolybdate. Tetrathiomolybdate is a novel de-coppering agent – meaning it reduces the body’s level of copper – with high affinity and selectivity for copper.


• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Web:
Contact:
 
 
Västra trädgårdsgatan 15
Stockholm SE-111 53
Sweden
+46709441877
http://www.wilsontherapeutics.com
Jonas Hansson
+46709441877

Company Facts
Founded:Dec 2012
Founders:
CEO:Jonas Hansson
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


23,644
Tech investments
From our Online Data Service
15,269
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 10€2.3MSoftware development
Dec 6€5.0MIT services
Dec 5€26.0MEnergy related
Dec 5€5.5MSecurity
Dec 5€16.0MKnowledge management
Dec 4€25.0MBiopharmaceuticals
Dec 4€8.0MInternet services

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises 37.5 million in series a

Apr 5
Fliit
logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...

Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...





About usContact usLegal Information
Copyright 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.